2017

MANCHACA, Texas — When California rings in the new year with the sale of recreational pot for the first time, Texas will be tiptoeing into its own marijuana milestone: a medical cannabis program so restrictive that doubts swirl over who will even use it. Texas is the last big state to allow some form of […]

by

PHILADELPHIA — Children’s Hospital of Philadelphia is pairing with an Australian biopharmaceutical company in what some advocates say could be the first major effort in the United States to study the effects of medical marijuana on children with autism. Athena Zuppa, the director of the hospital’s Center for Clinical Pharmacology, will lead a team researching […]

by

BERKELEY, Calif., Dec. 15, 2017 /PRNewswire/ – Steep Hill, the global leader in cannabis science, will collaborate with University of Technology, Jamaica(UTech, JA) at this weekend’s Rastafari RootzFest, leveraging Steep Hill Express to provide accurate potency testing for the event. Steep Hill will also provide testing training to UTech, JA to help promote best practices and […]

by

Dec. 15, 2017 — A compound found in the cannabis plant is not harmful, has health benefits, and does not have abuse potential, experts at the World Health Organization say. The WHO’s Expert Committee on Drug Dependence focused on cannabidiol, or CBD, one of the naturally occurring cannabinoids found in cannabis plants. After reviewing evidence […]

by

reader comments 90 The US Drug Enforcement Administration has long held that the non-psychoactive component of marijuana, cannabidiol, is a schedule I drug. That is, a drug that has no accepted medical use and a high potential for abuse. But according to a preliminary report embraced by the World Health Organization this week, the DEA’s […]

by

When California rings in the new year with the sale of recreational pot for the first time, Texas will be tiptoeing into its own marijuana milestone: a medical cannabis program so restrictive that doubts swirl over who will even use it. Texas is the last big state to allow some form of medical marijuana, albeit […]

by

LONDON —  An ingredient in cannabis called cannabidiol or CBD has shown promise in a clinical trial as a potential new treatment for psychosis, scientists said Friday. In research involving 88 people with psychosis, a mental disorder characterized by anxiety, paranoia and hallucinations, the scientists found patients treated with CBD had lower levels of psychotic […]

by